Iris Kloots - Radboud University Medical Centre (Radboudumc)

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

40 Identification of Clinical Biomarkers in Blood Liquid Biopsies for Clinical Benefit Prediction in Highly Mutated Castration-Resistant Prostate Cancer Patients Treated with Immune-Checkpoint Inhibitors

Davide Croci,Sandra van Wilpe,Iris Kloots, Sara Fonseca Costa, Simona Pavan, Laura Ciarloni, Sahar Hosseinian Ehrensberger,Pedro Romero, Niven Mehra

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

Impact of TP53 Loss-of-function Alterations on the Response to PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Peter H. J. Slootbeek,Maria Victoria Luna-Velez,Bastiaan M. Prive,Maarten J. van der Doelen,Iris S. H. Kloots,Samhita Pamidimarri Naga, Hilde E. Onstenk,James Nagarajah,Harm Westdorp,Inge M. van Oort,Leonie I. Kroeze,Jack. A. Schalken,Haiko J. Bloemendal,Niven Mehra

Theranosticsno. 12 (2024): 4555-4569

引用0浏览0WOS引用

LBA72 Nivolumab 3mg/kg and Ipilimumab 1mg/kg (nivo3/ipi1) in Molecularly Selected Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

N. Mehra,S. Van Wilpe,H. Westdorp,I. Kloots, P. Slootbeek,M. den Brok, M. Franken,M. Coskuntürk, H. Bloemendal,J. Nagarajah, J. van Ipenburg,L. Kroeze,M. Ligtenberg, J.A. Schalken,W.R. Gerritsen

Annals of Oncology (2024)

引用0浏览0引用

Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer

Levi Groen,Iris Kloots,David Englert,Kelly Seto, Lana Estafanos, Paul Smith,Gerald W. Verhaegh,Niven Mehra,Jack A. Schalken

International Journal of Molecular Sciencesno. 10 (2023): 9002-9002

引用0浏览0WOS引用

Cross-Resistance Between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer

Peter H. J. Slootbeek,Iris S. H. Kloots,Inge M. van Oort,Leonie I. Kroeze,Jack A. Schalken,Haiko J. Bloemendal,Niven Mehra

CANCERSno. 10 (2023)

引用0浏览0WOS引用

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

European Urology Open Science（2023）

引用0浏览0WOS引用

Impact of Molecular Tumour Board Discussion on Targeted Therapy Allocation in Advanced Prostate Cancer (vol 126, Pg 907, 2022)

Peter H. J. Slootbeek,Iris S. H. Kloots,Minke Smits, Inge M. van Oort,Winald R. Gerritsen,Jack A. Schalken,Marjolijn J. L. Ligtenberg,Katrien Grunberg,Leonie I. Kroeze,Haiko J. Bloemendal,Niven Mehra

BRITISH JOURNAL OF CANCERno. 7 (2022): 1108-1108

引用0浏览0引用

First Results of the PROMPT Trial: Precision Oncology Allocation in Patients with Early Castration-Resistant Prostate Cancer Following Routine Molecular Profiling

Iris S. H. Kloots,Peter H. J. Slootbeek,Minke Smits,Sjoerd van Helvert,Leonie I. Kroeze,Marleen Kets,Katrien Grunberg,Jolique van Ipenburg,Marjolijn Ligtenberg,Jack A. Schalken,Inge M. van Oort,Haiko Bloemendal,Winald R. Gerritsen,Niven Mehra

Journal of clinical oncology（2022）

引用0浏览0引用

Impact of Molecular Tumour Board Discussion on Targeted Therapy Allocation in Advanced Prostate Cancer

Peter H. J. Slootbeek,Iris S. H. Kloots,Minke Smits,Inge M. van Oort,Winald R. Gerritsen,Jack A. Schalken,Marjolijn J. L. Ligtenberg,Katrien Grunberg,Leonie Kroeze,Haiko J. Bloemendal,Niven Mehra

BRITISH JOURNAL OF CANCER（2022）

引用4浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn